Results 101 to 110 of about 21,582 (203)

Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Critical Narrative Review and an Evidence-Graded Approach to Agent Selection. [PDF]

Antibodies (Basel)
Guarino L, Rizzuto G, Coppolelli V, Scipione A, Scattone M, Gargano L, Scribani Rossi P, Del Duca E, Dattola A, Pellacani G, Nisticò S, Chello C.   +11 more
europepmc   +1 more source

Studying the remix

STUDYING THE REMIX Studying the remix / Heinrich, Anna Juliane (Rights reserved) (-
Heinrich, Anna Juliane, Heitmayer, Maxi
core  

Emerging and Newly Approved Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Narrative Review. [PDF]

Diseases
Asiri RS, Amer KA, Sarhan LA, Jahash NA, Alharbi RH.   +4 more
europepmc   +1 more source

Blockchain-based solution for secure and transparent pharmaceutical supply chain management using drugledger. [PDF]

Sci Rep
Dutta D, G P.
europepmc   +1 more source

A framework for reproducibly managing coupled research software and data assets based on shared transformation functions. [PDF]

Patterns (N Y)
Kuckertz P, Fuchs B, Schönau J, Gardian H, Knosala K, Arellano Ruiz ES, Göpfert J, Gils HC, Weinand JM, Jochem P, Linßen J, Stolten D.   +11 more
europepmc   +1 more source

Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies. [PDF]

Am J Clin Dermatol
Schmidt E, Puga MF, Kim BS, Simpson EL.
europepmc   +1 more source

Learnable frozen feature augmentation for few-shot biomarker prediction from pathology whole-slide images. [PDF]

Bioinformatics
Zhang D, Liu J, Ma Y, Ge J, Zeng Z, Sun W, Liu Q, He K, Zheng Y, Yu W, Li C, Gao Z.   +11 more
europepmc   +1 more source

A new era in chronic spontaneous urticaria: FDA approval of the oral BTK inhibitor remibrutinib. [PDF]

Ann Med Surg (Lond)
Jan M, Qazi K, Noor A, Naveed M, Khalid M, Waafira A.   +5 more
europepmc   +1 more source

The benefits of exploring a large scenario space for future energy systems. [PDF]

Nat Commun
Frey UJ, Cao KK, Sasanpour S, Buschmann J, Breuer T.   +4 more
europepmc   +1 more source

Efficacy of Remibrutinib versus Dupilumab at Early Timepoints in Chronic Spontaneous Urticaria: US Phase 3b Study Design (RECLAIM). [PDF]

Dermatol Ther (Heidelb)
Yosipovitch G, Mosnaim G, Ortmann CE, Griswold N, Mast J, Martzloff ED, Rodrigues J, Hawkes JE.   +7 more
europepmc   +1 more source